GlassScriptPhysician profile
Sandra Kamba
NPI 1962134692
$599.90
in general payments reported to CMS, 2019-2025
9 companies · $31.11 in 2025
The $31.11 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $443 · 2024: $23.07 · 2025: $31.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.12 | 2022-2023 | Wegovy, Saxenda, Ozempic |
| Averitas Pharma INC. | $121.09 | 2023 | Qutenza |
| Pfizer INC. | $87.40 | 2023 | |
| Viiv Healthcare Company | $51.59 | 2023-2024 | Apretude |
| Lilly USA, LLC | $33.13 | 2022-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $32.83 | 2022 | |
| Glaxosmithkline, LLC. | $31.11 | 2025 | Bexsero |
| Organon LLC | $30.67 | 2022 | |
| Cranial Technologies, INC | $14.96 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Kamba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.